Companion Diagnostics Guidance Finalized, But LDT Context Will Be Key

FDA has finalized its guidance on companion diagnostics with very few revisions from the draft it released three years ago. But the final guidance was released simultaneously with FDA’s much-delayed proposal to begin actively regulating lab-developed tests, which presents important underlying questions for companion diagnostic policy.